Four small firms hit as US FDA takes a new step in war on unauthorised vapes

The US Food and Drug Administration (FDA) has for the first time filed civil money penalty (CMP) complaints against four small vaping companies for manufacturing and selling e-liquids without marketing authorisation.

The CMPs, which the FDA has authority to assess for violations of the Food, Drug, and Cosmetic (FD&C) Act, carry a maximum penalty of $19,192 per violation. The complaints have been filed as part of what Brian King, director of the FDA’s Center for Tobacco Products (CTP) described as “a comprehensive approach to actively identify violations actively and to deter illegal conduct”.

Read full article
I'm already a subscriber

Antonia Di Lorenzo

Assistant news editor/senior reporter
Antonia is a member of the editorial team and holds a masters degree in Law from the University of Naples Federico II, Italy. She moved in 2013 to London, where she completed a postgraduate course at the London School of Journalism. In the UK, she worked as a news reporter for a financial newswire and a magazine before moving to Barcelona in 2019.

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization